Abnormal circling behavior in rat mutants and its relevance to model specific brain dysfunctions

Neuroscience and Biobehavioral Reviews

Volumn 34, Issue 1, 2010, Pages 31-49

  Löscher, Wolfgang ^a,b  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

Basal ganglia; Brain asymmetries; Dopamine; Parkinson's disease; Schizophrenia; Tourette syndrome; Usher syndrome

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; LEVODOPA;

ABNORMAL BEHAVIOR; AMINO ACID SUBSTITUTION; ATAXIA; ATTENTION DEFICIT DISORDER; BASAL GANGLION; BRAIN ASYMMETRY; BRAIN DYSFUNCTION; CHROMOSOME 10; CIRCLING BEHAVIOR; DEPRESSION; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; EVOKED AUDITORY RESPONSE; FOREBRAIN; GENETIC MODEL; GILLES DE LA TOURETTE SYNDROME; HYPERACTIVITY; INNER EAR DISEASE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OPEN FIELD BEHAVIOR; OPISTHOTONUS; PARKINSON DISEASE; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; USHER SYNDROME; VENTRAL TEGMENTUM; VESTIBULAR DISORDER; VESTIBULAR SYSTEM;

ANIMALS; BRAIN; BRAIN DISEASES; DISEASE MODELS, ANIMAL; HUMANS; MOTOR ACTIVITY; RATS; RATS, MUTANT STRAINS; ROTATION;

EID: 70350214944     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2009.07.001     Document Type: Review

References (168)

1. Accili D., Fishburn C.S., Drago J., Steiner H., Lachowicz J.E., Park B.H., Gauda E.B., Lee E.J., Cool M.H., Sibley D.R., Gerfen C.R., Westphal H., and Fuchs S. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 1945-1949
2. Alagramam K.N., Kwon H.Y., Cacheiro N.L., Stubbs L., Wright C.G., Erway L.C., and Woychik R.P. A new mouse insertional mutation that causes sensorineural deafness and vestibular defects. Genetics 152 (1999) 1691-1699
3. Albin R.L., and Mink J.W. Recent advances in Tourette syndrome research. Trends Neurosci. 29 (2006) 175-182
4. Al Fayez M., Russell D., Wayne D.R., Shiels P.G., Baker P.J., and Payne A.P. Deficits in the mid-brain raphe nuclei and striatum of the AS/AGU rat, a protein kinase C-gamma mutant. Eur. J Neurosci. 22 (2005) 2792-2798
5. Alleva F.R., and Balazs T. Toxic effects of postnatal administration of streptomycin sulfate to rats. Toxicol. Appl. Pharmacol. 45 (1978) 859
6. Alleva F.R., and Balazs T. Age-dependent sensitivity of the rat to neurotoxic effects of streptomycin. Toxicol. Lett. 6 (1980) 385-389
7. Anderson D.W., Probst F.J., Belyantseva I.A., Fridell R.A., Beyer L., Martin D.M., Wu D., Kachar B., Friedman T.B., Raphael Y., and Camper S.A. The motor and tail regions of myosin XV are critical for normal structure and function of auditory and vestibular hair cells. Hum. Mol. Genet. 9 (2000) 1729-1738
8. Anniko M., Sobin A., and Wersall J. Vestibular hair cell pathology in the Shaker-2 mouse. Arch. Otorhinolaryngol. 226 (1980) 45-50
9. Balaban C.D. Neural substrates linking balance control and anxiety. Physiol. Behav. 77 (2002) 469-475
10. Belyantseva I.A., Boger E.T., and Friedman T.B. Myosin XVa localizes to the tips of inner ear sensory cell stereocilia and is essential for staircase formation of the hair bundle. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13958-13963
11. Belyantseva I.A., Boger E.T., Naz S., Frolenkov G.I., Sellers J.R., Ahmed Z.M., Griffith A.J., and Friedman T.B. Myosin-XVa is required for tip localization of whirlin and differential elongation of hair-cell stereocilia. Nat. Cell Biol. 7 (2005) 148-156
12. Blandini F., Armentero M.T., and Martignoni E. The 6-hydroxydopamine model: news from the past. Parkinsonism Relat. Disord. 14 Suppl. 2 (2008) S124-S129
13. Bloom D., and Hultcrantz M. Vestibular morphology in relation to age and circling behavior. Acta Otolaryngol. 114 (1994) 387-392
14. Breckler J., Au K., Cheng J., Hasson T., and Burnside B. Novel myosin VI isoform is abundantly expressed in retina. Exp. Eye Res. 70 (2000) 121-134
15. Brett P., Robertson M., Gurling H., and Curtis D. Failure to find linkage and increased homozygosity for the dopamine D3 receptor gene in Tourette's syndrome. Lancet 341 (1993) 1225
16. Brock J.W., and Ashby Jr. C.R. Evidence for genetically mediated dysfunction of the central dopaminergic system in the stargazer rat. Psychopharmacology 123 (1996) 199-205
17. Brock J.W., Truett G.E., Ross K.D., and Kloster C.A. Quantitative analysis of abnormal spontaneous behavior and clinical assessment of the stargazer rat. Lab. Anim. Sci. 45 (1995) 276-280
18. Brock J.W., Bond S.P., Ross K.D., Farooqui S.M., and Kloster C.A. Abnormal behaviors in the stargazer rat are maladaptive, but not anxiety-related. Physiol. Behav. 59 (1996) 1011-1014
19. Campbell J.M., Payne A.P., Gilmore D.P., Byrne J.E., Russell D., McGadey J., Clarke D.J., Davies R.W., and Sutcliffe R.G. Neostriatal dopamine depletion and locomotor abnormalities due to the Albino Swiss rat agu mutation. Neurosci. Lett. 213 (1996) 173-176
20. Carlson J.N., and Glick S.D. Cerebral lateralization as a source of interindividual differences in behaviour. Experientia 45 (1989) 788-798
21. Carlson J.N., and Glick S.D. Cerebral laterality as a determinant of behavioral function and dysfunction. In: Driscoll P. (Ed). Genetically Defined Animal Models of Neurobehavioral Dysfunctions (1992), Birkhäuser, Boston 189-216
22. Carlson J.N., and Glick S.D. Circling behavior in rodents. Methodology, biology, and functional implications. In: Sanberg P.R., Ossenkopp K.P., and Kavaliers M. (Eds). Motor Activity and Movement Disorders. Research Issues and Applications (1996), Humana Press, Totowa 269-300
23. Chwalisz, W., 2003. Genetische Charakterisierung der LEW/Ztm-ci2 (circling2) und der BH.7A/Ztm-ci3 (circling3) Ratte als Modelle für Taubblindheit des Menschen (USH1) bzw. Lateralisierung von Hirnfunktionen und Hyperlokomotion (Genetical Characterization of the LEW/Ztm-ci2 (circling2) and the BH.7A/Ztm-ci3 (circling3) rats as Animal Models for Syndromic Deafness (USH1) Respectively Lateralization of Brain Function and Hyperlocomotion (http://elib.tiho-hannover.de/dissertations/chwaliszw_ws03.pdf). Doctoral Thesis. University of Veterinary Medicine Hannover, Hannover.
24. Chwalisz W.T., Koelsch B.U., Kindler-Rohrborn A., Hedrich H.J., and Wedekind D. The circling behavior of the deafblind LEW-ci2 rat is linked to a segment of RNO10 containing Myo15 and Kcnj12. Mamm. Genome 14 (2003) 620-627
25. Clarke D.J., and Payne A.P. Neuroanatomical characterization of a new mutant rat with dopamine depletion in the substantia nigra. Eur. J. Neurosci. 6 (1994) 885-888
26. Craig N.J., Duran Alonso M.B., Hawker K.L., Shiels P., Glencorse T.A., Campbell J.M., Bennett N.K., Canham M., Donald D., Gardiner M., Gilmore D.P., MacDonald R.J., Maitland K., McCallion A.S., Russell D., Payne A.P., Sutcliffe R.G., and Davies R.W. A candidate gene for human neurodegenerative disorders: a rat PKC gamma mutation causes a Parkinsonian syndrome. Nat. Neurosci. 4 (2001) 1061-1062
27. Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res. 835 (1999) 18-26
28. Crow T.J. The 'big bang' theory of the origin of psychosis and the faculty of language. Schizophr. Res. 102 (2008) 31-52
29. Dawe G.S., and Ratty A.K. The chakragati mouse: a mouse model for rapid in vivo screening of antipsychotic drug candidates. Biotechnol. J. 2 (2007) 1344-1352
30. de Waele C., Graf W., Josset P., and Vidal P.P. A radiological analysis of the postural syndromes following hemilabyrinthectomy and selective canal and otolith lesions in the guinea pig. Exp. Brain Res. 77 (1989) 166-182
31. Deerberg F., Kaspareit J., and Reetz I.C. Circling (ci), a new neurological mutant in the rat. Rat News Lett. 21 (1989) 19
32. Deol M.S. The anatomy and development of the mutants pirouette, shaker-1 and waltzer in the mouse. Proc. R. Soc. Lond. B Biol. Sci. 145 (1956) 206-213
33. Devor E.J., Dill-Devor R.M., and Magee H.J. The Bal I and Msp I polymorphisms in the dopamine D3 receptor gene display, linkage disequilibrium with each other but no association with Tourette syndrome. Psychiatr. Genet. 8 (1998) 49-52
34. Ebermann I., Scholl H.P., Charbel I.P., Becirovic E., Lamprecht J., Jurklies B., Millan J.M., Aller E., Mitter D., and Bolz H. A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss. Hum. Genet. 121 (2007) 203-211
35. el Ayadi A., and Errami M. Interactions between neomycin and cerebral dopaminergic and serotoninergic transmission in rats. Therapie 54 (1999) 595-599
36. Emborg M.E. Nonhuman primate models of Parkinson's disease. ILAR J. 48 (2007) 339-355
37. Erenberg G. The relationship between Tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review. Semin. Pediatr. Neurol. 12 (2005) 217-221
38. Ernstson S. Vestibular physiology in a strain of the waltzing guinea pig. Acta Otolaryngol. 72 (1971) 303-309
39. Fallon J.H., and Loughlin S.E. Substantia nigra. In: Paxinos G. (Ed). The Rat Nervous System (1995), Academic Press, New York 215-238
40. Fedrowitz M., Potschka H., Richter A., and Löscher W. A microdialysis study of striatal dopamine release in the circling rat, a genetic animal model with spontaneous lateralized rotational behavior. Neuroscience 97 (2000) 69-77
41. Fedrowitz M., Lindemann S., Löscher W., and Gernert M. Altered spontaneous discharge rate and pattern of basal ganglia output neurons in the circling (ci2) rat mutant. Neuroscience 118 (2003) 867-878
42. Fitzgerald L.W., Ratty A.K., Miller K.J., Ellsworth M.K., Glick S.D., and Gross K.W. Ontogeny of hyperactivity and circling behavior in a transgenic insertional mutant mouse. Behav. Neurosci. 105 (1991) 755-763
43. 2 receptor in the chakragati mouse: neurobehavioral dysfunction in a transgenic insertional mutant. Brain Res. 580 (1992) 18-26
44. Franklin K.B., and Wolfe J. Opposed locomotor asymmetries following lesions of the medial and lateral substantia nigra pars compacta or pars reticulata in the rat. Physiol. Behav. 40 (1987) 741-745
45. Friedman T.B., Sellers J.R., and Avraham K.B. Unconventional myosins and the genetics of hearing loss. Am. J. Med. Genet. 89 (1999) 147-157
46. Friedman L.M., Dror A.A., and Avraham K.B. Mouse models to study inner ear development and hereditary hearing loss. Int. J. Dev. Biol. 51 (2007) 609-631
47. Fuji J., Fukuda R., Imoto F., and Ooshima Y. New behavioral mutant rat exhibiting circling behavior (clx) controlled by a sex-linked recessive gene. Congenit. Anom. (Kyoto) 42 (2002) 187-193
48. Fuji J., Tanabe H., Fukuda R., and Ooshima Y. Defective balancing ability and hyperactivity in the CLX (circling behavior linked to the X-chromosome) mutant rat. Congenit. Anom. (Kyoto) 43 (2003) 294-301
49. Fukuda R., Fuji J., Miyamoto Y.S.Y., and Ooshima Y. Hereditary circling behavior in rats: a histopathological study. The 35th Annual Meeting of the Japanese Teratology Society. Tokyo, Japan, July 27-29, 1995 (1995) 381
50. Gardner E.I., Mishra R.K., Iordanidis P., Katzman R., and Makman M.H. Catalytic and receptor components of enhanced dopamine-stimulated adenylate cyclase in two behaviorally distinct striatal denervation syndromes. Fed. Proc. 35 (1976) 456
51. Gibbs D., Kitamoto J., and Williams D.S. Abnormal phagocytosis by retinal pigmented epithelium that lacks myosin VIIa, the Usher syndrome 1B protein. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 6481-6486
52. Glick S.D., Jerussi T.P., and Fleisher L.N. Turning in circles: the neuropharmacology of rotation. Life Sci. 18 (1976) 889-896
53. Gockeln R., Lindemann S., Kamino K., Hedrich H., Winter R., and Löscher W. Retinitis pigmentosa in spontaneous rat mutants with sensorineural deafness and vestibular dysfunction-a rodent model for Usher syndrome phenotype 1. Invest. Ophthalmol. Vis. Sci. 44 (2003) E-Abstract 1861
54. Gray Jr. L.E., Rogers J.M., Ostby J.S., Kavlock R.J., and Ferrell J.M. Prenatal dinocap exposure alters swimming behavior in mice due to complete otolith agenesis in the inner ear. Toxicol. Appl. Pharmacol. 92 (1988) 266-273
55. Halliday G.M. A review of the neuropathology of schizophrenia. Clin. Exp. Pharmacol. Physiol. 28 (2001) 64-65
56. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122 Pt 4 (1999) 593-624
57. Harvey B.H., Brand L., Jeeva Z., and Stein D.J. Cortical/hippocampal monoamines, HPA-axis changes and aversive behavior following stress and restress in an animal model of post-traumatic stress disorder. Physiol. Behav. 87 (2006) 881-890
58. Hasson T., Heintzelman M.B., Santos-Sacchi J., Corey D.P., and Mooseker M.S. Expression in cochlea and retina of myosin VIIa, the gene product defective in Usher syndrome type 1B. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 9815-9819
59. Hebebrand J., Nothen M.M., Lehmkuhl G., Poustka F., Schmidt M., Propping P., and Remschmidt H. Tourette's syndrome and homozygosity for the dopamine D3 receptor gene. German Tourette's Syndrome Collaborative Research Group. Lancet 341 (1993) 1483-1484
60. Hedrich H.-J. Genetic Monitoring of Inbred Strains of rats (1990), Gustav Fischer, Stuttgart
61. Held, N., 2007. Strukturelle, funktionelle und genetische Analyse der LEW/Ztm-ci2 Ratte - ein Tiermodell für syndromale Taubheit (Structural, functional and genetic analysis of the LEW/Ztm-ci2 rat - an animal model for syndromal deafness) (http://elib.tiho-hannover.de/dissertations/heldn_ss07.pdf). Doctoral thesis, University of Veterinary Medicine Hannover, Hannover.
62. Hodge G.K., and Butcher L.L. Role of pars compacta of the substantia nigra in circling behavior. Pharmacol. Biochem. Behav. 10 (1979) 695-709
63. Hudson J.L., van Horne C.G., Strömberg I., Brock S., Clayton J., Masserano J., Hoffer B.J., and Gerhardt G.A. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res. 626 (1993) 167-174
64. Hunt M.A., Miller S.W., Nielson H.C., and Horn K.M. Intratympanic injection of sodium arsanilate (atoxyl) solution results in postural changes consistent with changes described for labyrinthectomized rats. Behav. Neurosci. 101 (1987) 427-428
65. Jacobson S.G., Cideciyan A.V., Aleman T.S., Sumaroka A., Roman A.J., Gardner L.M., Prosser H.M., Mishra M., Bech-Hansen N.T., Herrera W., Schwartz S.B., Liu X.Z., Kimberling W.J., Steel K.P., and Williams D.S. Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. Hum. Mol. Genet. 17 (2008) 2405-2415
66. Jellinger K. The pathology of parkinsonism. In: Marsden C.D., and Fahn S. (Eds). Movement Disorders 2 (1987), Butterworths, London 124-165
67. Jellinger K. New developments in the pathology of Parkinson's disease. Adv. Neurol. 53 (1990) 1-16
68. Jellinger K.A. Post mortem studies in Parkinson's disease-is it possible to detect brain areas for specific symptoms?. J. Neural Transm. Suppl. 56 (1999) 1-29
69. Jero J., Coling D.E., and Lalwani A.K. The use of Preyer's reflex in evaluation of hearing in mice. Acta Otolaryngol. 121 (2001) 585-589
70. Joel D., and Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 96 (2000) 451-474
71. Joseph J.D., Wang Y.M., Miles P.R., Budygin E.A., Picetti R., Gainetdinov R.R., Caron M.G., and Wightman R.M. Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors. Neuroscience 112 (2002) 39-49
72. Joyce J.N. Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs. Pharmacol. Ther. 90 (2001) 231-259
73. Kaakkola S., and Teravainen H. Animal models of Parkinsonism. Pharmacol. Toxicol. 67 (1990) 95-100
74. Kaiser A., Fedrowitz M., Ebert U., Zimmermann E., Hedrich H.J., Wedekind D., and Löscher W. Auditory and vestibular defects in the circling (ci2) rat mutant. Eur. J. Neurosci. 14 (2001) 1129-1142
75. Kazlauskas M.A., and Kelland M.D. Behavioral evaluation of the stargazer mutant rat in a tactile startle. Psychiatr. J. (1997) 2
76. Keats B.J., and Corey D.P. The usher syndromes. Am. J. Med. Genet. 89 (1999) 158-166
77. King H.D. A waltzing mutation in the white rat. J. Mammal. 17 (1936) 157-163
78. Kitamura K., Yagi M., Yoshikawa Y., Ochidubo F., and Kato M. Vestibular pathology in a new-mutant mouse. Acta Otolaryngol. Suppl. 481 (1991) 121-124
79. Klemm W.R. Drug effects on active immobility responses: what they tell us about neurotransmitter systems and motor functions. Prog. Neurobiol. 32 (1989) 403-422
80. Klieger P.S., Fett K.A., Dimitsopulos T., and Kurlan R. Asymmetry of basal ganglia perfusion in Tourette's syndrome shown by technetium-99m-HMPAO SPECT. J. Nucl. Med. 38 (1997) 188-191
81. Koeltzow T.E., Xu M., Cooper D.C., Hu X.T., Tonegawa S., Wolf M.E., and White F.J. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J. Neurosci. 18 (1998) 2231-2238
82. Kremer H., van Wijk E., Marker T., Wolfrum U., and Roepman R. Usher syndrome: molecular links of pathogenesis, proteins and pathways. Hum. Mol. Genet. 15 Spec No. 2 (2006) R262-R270
83. Larson R.E. Myosin-V: a class of unconventional molecular motors. Braz. J. Med. Biol. Res. 29 (1996) 309-318
84. Le Foll B., Diaz J., and Sokoloff P. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice. Life Sci. 76 (2005) 1281-1296
85. Lessenich A., Lindemann S., Richter A., Hedrich H.J., Wedekind D., Kaiser A., and Löscher W. A novel black-hooded mutant rat (ci3) with spontaneous circling behavior but normal auditory and vestibular functions. Neuroscience 107 (2001) 615-628
86. Levan G., Hedrich H.J., Remmers E.F., Serikawa T., and Yoshida M.C. Standardized rat genetic nomenclature. Mamm. Genome 6 (1995) 447-448
87. Liang Y., Wang A., Belyantseva I.A., Anderson D.W., Probst F.J., Barber T.D., Miller W., Touchman J.W., Jin L., Sullivan S.L., Sellers J.R., Camper S.A., Lloyd R.V., Kachar B., Friedman T.B., and Fridell R.A. Characterization of the human and mouse unconventional myosin XV genes responsible for hereditary deafness DFNB3 and shaker 2. Genomics 61 (1999) 243-258
88. Lindemann S., Lessenich A., Ebert U., and Löscher W. Spontaneous paroxysmal circling behavior in the ci2 rat mutant: epilepsy with rotational seizures or hyperkinetic movement disorder?. Exp. Neurol. 172 (2001) 437-445
89. Lindemann S., Kamino K., Wedekind D., Hedrich H., Winter R., Löscher W., and Gockeln R. Histological examination in a blind-deafness rat mutant-a rodent model for Usher syndrome phenotype 1. Invest. Ophthalmol. Vis. Sci. 44 (2003) E-Abstract 2820
90. Lindemann S., Gernert M., Bennay M., Koch M., and Loscher W. Comparative analysis of anxiety-like behaviors and sensorimotor functions in two rat mutants, ci2 and ci3, with lateralized rotational behavior. Physiol. Behav. 93 (2008) 417-426
91. Liu X., Ondek B., and Williams D.S. Mutant myosin VIIa causes defective melanosome distribution in the RPE of shaker-1 mice. Nat. Genet. 19 (1998) 117-118
92. Liu X., Udovichenko I.P., Brown S.D., Steel K.P., and Williams D.S. Myosin VIIa participates in opsin transport through the photoreceptor cilium. J. Neurosci. 19 (1999) 6267-6274
93. Löscher W., Annies R., and Hönack D. The N-methyl-d-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci. Lett. 128 (1991) 191-194
94. Löscher W., Richter A., Nikkhah G., Rosenthal C., Ebert U., and Hedrich H.-J. Behavioural and neurochemical dysfunction in the circling (ci) rat: a novel genetic animal model of a movement disorder. Neuroscience 74 (1996) 1135-1142
95. Lyon M.F., and Searle A.G. Genetic Variants and Strains of the Laboratory Mouse (1989), Oxford University Press, Oxford
96. Maerker T., van Wijk E., Overlack N., Kersten F.F., McGee J., Goldmann T., Sehn E., Roepman R., Walsh E.J., Kremer H., and Wolfrum U. A novel Usher protein network at the periciliary reloading point between molecular transport machineries in vertebrate photoreceptor cells. Hum. Mol. Genet. 17 (2008) 71-86
97. Marszalek J.R., Liu X., Roberts E.A., Chui D., Marth J.D., Williams D.S., and Goldstein L.S. Genetic evidence for selective transport of opsin and arrestin by kinesin-II in mammalian photoreceptors. Cell 102 (2000) 175-187
98. Mburu P., Mustapha M., Varela A., Weil D., El Amraoui A., Holme R.H., Rump A., Hardisty R.E., Blanchard S., Coimbra R.S., Perfettini I., Parkinson N., Mallon A.M., Glenister P., Rogers M.J., Paige A.J., Moir L., Clay J., Rosenthal A., Liu X.Z., Blanco G., Steel K.P., Petit C., and Brown S.D. Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31. Nat. Genet. 34 (2003) 421-428
99. Mei Yoke G.A., Bradshaw J.L., Bradshaw J.A., and Georgiou-Karistianis N. Inhibition of expected movements in Tourette's syndrome. J. Clin. Exp. Neuropsychol. 24 (2002) 1017-1031
100. Mermall V., Post P.L., and Mooseker M.S. Unconventional myosins in cell movement, membrane traffic, and signal transduction. Science 279 (1998) 527-533
101. Mikami M., Tachikawa E., and Kashimoto T. Effects of gentamicin on catecholamine levels in the striatum, hypothalamus, adrenal gland and vas deferens. Eur. J Pharmacol. 210 (1992) 91-96
102. Milani R. Spontaneous occurrence of brown and waltzer mutants in Rattus norvegicus. Ital. J. Zool. 65 (1988) 273-283
103. Millan M.J. The neurobiology and control of anxious states. Prog. Neurobiol. 70 (2003) 83-244
104. Morelli M., Porceddu M.L., Imperato A., and Di Chiara G. Role of substantia nigra pars reticulata neurons in the expression of neuroleptic-induced catalepsy. Brain Res. 217 (1981) 375-379
105. Mustapha M., Beyer L.A., Izumikawa M., Swiderski D.L., Dolan D.F., Raphael Y., and Camper S.A. Whirler mutant hair cells have less severe pathology than shaker 2 or double mutants. J. Assoc. Res. Otolaryngol. 8 (2007) 329-337
106. Noebels J.L., Qiao X., Bronson R.T., Spencer C., and Davisson M.T. Stargazer: a new neurological mutant on chromosome 15 in the mouse with prolonged cortical seizures. Epilepsy Res. 7 (1990) 129-135
107. Nomura Y., and Segawa M. Neurology of Tourette's syndrome (TS) TS as a developmental dopamine disorder: a hypothesis. Brain Dev. 25 Suppl. 1 (2003) S37-S42
108. Oliver T.N., Berg J.S., and Cheney R.E. Tails of unconventional myosins. Cell Mol. Life Sci. 56 (1999) 243-257
109. Ossenkopp K.P., Prkacin A., and Hargreaves E.L. Sodium arsanilate-induced vestibular dysfunction in rats: effects on open-field behavior and spontaneous activity in the automated digiscan monitoring system. Pharmacol. Biochem. Behav. 36 (1990) 875-881
110. Palomero-Gallagher N., Schleicher A., Lindemann S., Lessenich A., Zilles K., and Löscher W. Receptor fingerprinting the circling ci2 rat mutant: insights into brain asymmetry and motor control. Exp. Neurol. 210 (2008) 624-637
111. Patel K.G., Liu C., Cameron P.L., and Cameron R.S. Myr 8, a novel unconventional myosin expressed during brain development associates with the protein phosphatase catalytic subunits 1alpha and 1gamma1. J. Neurosci. 21 (2001) 7954-7968
112. Payne A.P., Campbell J.M., Russell D., Favor G., Sutcliffe R.G., Bennett N.K., Davies R.W., and Stone T.W. The AS/AGU rat: a spontaneous model of disruption and degeneration in the nigrostriatal dopaminergic system. J. Anat. 196 (2000) 629-633
113. Peterson B.S. Neuroimaging in child and adolescent neuropsychiatric disorders. J. Am. Acad. Child Adolesc. Psychiatry 34 (1995) 1560-1576
114. Petit C. Usher syndrome: from genetics to pathogenesis. Annu. Rev. Genomics Hum. Genet. 2 (2001) 271-297
115. Petty R.G. Structural asymmetries of the human brain and their disturbance in schizophrenia. Schizophr. Bull. 25 (1999) 121-139
116. Pezze M.A., and Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Prog. Neurobiol. 74 (2004) 301-320
117. Probst F.J., Fridell R.A., Raphael Y., Saunders T.L., Wang A., Liang Y., Morell R.J., Touchman J.W., Lyons R.H., Noben-Trauth K., Friedman T.B., and Camper S.A. Correction of deafness in shaker-2 mice by an unconventional myosin in a BAC transgene. Science 280 (1998) 1444-1447
118. Pycock C.J. Turning behaviour in animals. Neuroscience 5 (1980) 461-514
119. Rabbath G., Necchi D., de Waele C., Gasc J.P., Josset P., and Vidal P.P. Abnormal vestibular control of gaze and posture in a strain of a waltzing rat. Exp. Brain Res. 136 (2001) 211-223
120. Ratty A.K., Fitzgerald L.W., Titeler M., Glick S.D., Mullins J.J., and Gross K.W. Circling behavior exhibited by a transgenic insertional mutant. Brain Res. Mol. Brain Res. 8 (1990) 355-358
121. Redgrave P., and Mitchell I. Functional validation of projection topography in the nigrostriatal dopamine system. Neuroscience 7 (1982) 885-894
122. Richardson G.P., Forge A., Kros C.J., Fleming J., Brown S.D., and Steel K.P. Myosin VIIA is required for aminoglycoside accumulation in cochlear hair cells. J. Neurosci. 17 (1997) 9506-9519
123. Richter A., Ebert U., Nobrega J.N., Vallbacka J.J., Fedrowitz M., and Löscher W. Immunohistochemical and neurochemical studies on nigral and striatal functions in the circling (ci) rat, a genetic animal model with spontaneous rotational behavior. Neuroscience 89 (1999) 461-471
124. Ridley R.M. The psychology of perserverative and stereotyped behaviour. Prog. Neurobiol. 44 (1994) 221-231
125. Rogers M.J., Fleming J., Kiernan B.W., Mburu P., Varela A., Brown S.D., and Steel K.P. Genetic mapping of the whirler mutation. Mamm. Genome 10 (1999) 513-519
126. Rosen G.D. Cellular, morphometric, ontogenetic and connectional substrates of anatomical asymmetry. Neurosci. Biobehav. Rev. 20 (1996) 607-615
127. Rubertone J.A., Mehler W.R., and Voogd J. The vestibular nuclear complex. In: Paxinos G. (Ed). The Rat Nervous System. second ed. (1995), Academic Press, San Diego 773-796
128. Saihan Z., Webster A.R., Luxon L., and Bitner-Glindzicz M. Update on Usher syndrome. Curr. Opin. Neurol. 22 (2009) 19-27
129. Schirmer M., Belyantseva I.A., Al-Fatah M., Pröpsting M., Gernert M., Fedrowitz M., Naim H.Y., Friedman T.B., and Löscher W. The role of myosin XVA in the phenotype of the circling (ci2) rat mutant. Naunyn-Schmiedeberg's Arch. Pharmacol. 369 Suppl. 1 (2004) R86
130. Schirmer M., Fedrowitz M., Gernert M., Lessenich A., Lindemann S., and Löscher W. Changes in 2-deoxyglucose uptake in discrete brain regions of the circling (ci2) rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 371 Suppl. 1 (2005) R77
131. Schirmer M., Kaiser A., Lessenich A., Lindemann S., Fedrowitz M., Gernert M., and Löscher W. Auditory and vestibular defects and behavioral alterations after neonatal administration of streptomycin to Lewis rats: Similarities and differences to the circling (ci2/ci2) Lewis rat mutant. Brain Res. 1155 (2007) 179-195
132. Schirmer M., Lessenich A., Lindemann S., and Löscher W. Marked differences in response to dopamine receptor antagonism in two rat mutants, ci2 and ci3, with lateralized rotational behavior. Behav. Brain Res. 180 (2007) 218-225
133. Schirmer M., Nobrega J.N., Harrison S.J., and Löscher W. Alterations in dopamine D3 receptors in the circling (ci3) rat mutant. Neuroscience 144 (2007) 1462-1469
134. Schrimsher G.W., Billingsley R.L., Jackson E.F., and Moore III B.D. Caudate nucleus volume asymmetry predicts attention-deficit hyperactivity disorder (ADHD) symptomatology in children. J. Child Neurol. 17 (2002) 877-884
135. Schwarting R.K.W., and Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog. Neurobiol. 50 (1996) 275-331
136. Schwarting R.K.W., and Huston J.P. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Progr. Neurobiol. 49 (1996) 215-266
137. Schwartz J.C., Levesque D., Martres M.P., and Sokoloff P. Dopamine D3 receptor: basic and clinical aspects. Clin. Neuropharmacol. 16 (1993) 295-314
138. Schwartz J.C., Diaz J., Pilon C., and Sokoloff P. Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions. Brain Res. Brain Res. Rev. 31 (2000) 277-287
139. Sekerkova G., Zheng L., Mugnaini E., and Bartles J.R. Espin actin-cytoskeletal proteins are in rat type I spiral ganglion neurons and include splice-isoforms with a functional nuclear localization signal. J. Comp Neurol. 509 (2008) 661-676
140. Seth P.K., Alleva F.R., and Balazs T. Alteration of high-affinity binding sites of neurotransmitter receptors in rats after neonatal exposure to streptomycin. Neurotoxicology 3 (1982) 13-19
141. Shapiro R.M., Glick S.D., and Hough L.B. Striatal dopamine uptake asymmetries and rotational behavior in unlesioned rats: revising the model?. Psychopharmacology (Berl) 89 (1986) 25-30
142. Shima F. Circling behavior depending on striopallidal and vestibular functions. In: Hassler R.G., and Christ J.F. (Eds). Advances in Neurology vol. 40 (1984), Raven Press, New York 47-54
143. Shima F., and Hassler R. Circling behavior produced by unilateral lesions of the central vestibular system. Appl. Neurophysiol. 45 (1982) 255-260
144. Shiroyama T., Kayahara T., Yasui Y., Nomura J., and Nakano K. Projections of the vestibular nuclei to the thalamus in the rat: a Phaseolus vulgaris leucoagglutinin study. J. Comp. Neurol. 407 (1999) 318-332
145. Smits B.M., Peters T.A., Mul J.D., Croes H.J., Fransen J.A., Beynon A.J., Guryev V., Plasterk R.H., and Cuppen E. Identification of a rat model for usher syndrome type 1B by N-ethyl-N-nitrosourea mutagenesis-driven forward genetics. Genetics 170 (2005) 1887-1896
146. Sokoloff P., Diaz J., Le Foll B., Guillin O., Leriche L., Bezard E., and Gross C. The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. CNS Neurol. Disord. Drug Targets 5 (2006) 25-43
147. Sousa A.D., Berg J.S., Robertson B.W., Meeker R.B., and Cheney R.E. Myo10 in brain: developmental regulation, identification of a headless isoform and dynamics in neurons. J. Cell Sci. 119 (2006) 184-194
148. Sullivan R.M. Hemispheric asymmetry in stress processing in rat prefrontal cortex and the role of mesocortical dopamine. Stress 7 (2004) 131-143
149. Sullivan R.M., and Gratton A. Prefrontal cortical regulation of hypothalamic-pituitary-adrenal function in the rat and implications for psychopathology: side matters. Psychoneuroendocrinology 27 (2002) 99-114
150. Swerdlow N.R., and Sutherland A.N. Preclinical models relevant to Tourette syndrome. Adv. Neurol. 99 (2006) 69-88
151. Thibodeau R., Jorgensen R.S., and Kim S. Depression, anxiety, and resting frontal EEG asymmetry: a meta-analytic review. J. Abnorm. Psychol. 115 (2006) 715-729
152. Torres G., Hallas B.H., Vernace V.A., Jones C., Gross K.W., and Horowitz J.M. A neurobehavioral screening of the ckr mouse mutant: implications for an animal model of schizophrenia. Brain Res. Bull. 62 (2004) 315-326
153. Truett G.E., Brock J.W., Lidl G.M., and Kloster C.A. Stargazer (stg), new deafness mutant in the Zucker rat. Lab. Anim. Sci. 44 (1994) 595-599
154. Truett G.E., Walker J.A., and Brock J.W. A rat homolog of the mouse deafness mutant jerker (je). Mamm. Genome 7 (1996) 356-358
155. Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5 (1968) 107-110
156. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. 82 Suppl. 367 (1971) 69-93
157. Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol. Scand. 82 Suppl. 367 (1971) 49-68
158. Usher C.H. On the inheritance of retinitis pigmentosa, with notes of cases. R. Lond. Ophthalmol. Hosp. Rep. 19 (1914) 130-236
159. Vaccarino F.J., Franklin K.B., and Prupas D. Opposite locomotor asymmetries elicited from the medial and lateral substantia nigra: role of the superior colliculus. Physiol. Behav. 35 (1985) 741-747
160. van Wijk E., van der Z.B., Peters T., Zimmermann U., Te B.H., Kersten F.F., Marker T., Aller E., Hoefsloot L.H., Cremers C.W., Cremers F.P., Wolfrum U., Knipper M., Roepman R., and Kremer H. The DFNB31 gene product whirlin connects to the Usher protein network in the cochlea and retina by direct association with USH2A and VLGR1. Hum. Mol. Genet. 15 (2006) 751-765
161. Wersall J., and Hawkins Jr. J.E. The vestibular sensory epithelia in the cat labyrinth and their reactions in chronic streptomycin intoxication. Acta Otolaryngol. 54 (1962) 1-23
162. Williams D.S. Usher syndrome: animal models, retinal function of Usher proteins, and prospects for gene therapy. Vision Res. 48 (2008) 433-441
163. Willis G.L., and Kennedy G.A. The implementation of acute versus chronic animal models for treatment discovery in Parkinson's disease. Rev. Neurosci. 15 (2004) 75-87
164. Wonigeit K. Characterization of the RT-Ly-1 and RT-Ly-2 alloantigenic systems by congenic rat strains. Transplant. Proc. 11 (1979) 1631-1635
165. Wu X., Jung G., and Hammer III J.A. Functions of unconventional myosins. Curr. Opin. Cell Biol. 12 (2000) 42-51
166. Xu M., Koeltzow T.E., Santiago G.T., Moratalla R., Cooper D.C., Hu X.T., White N.M., Graybiel A.M., White F.J., and Tonegawa S. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 19 (1997) 837-848
167. Yamazaki K., Mikami T., Kawaguchi A., Kuwabara M., Nozaki Y., Hosokawa S., Tagaya O., Katoh H., Yamamoto N., and Wakabayashi T. A new mutant rat with turning behavior (Tur). J. Hered. 86 (1995) 311-314
168. Zheng L., Sekerkova G., Vranich K., Tilney L.G., Mugnaini E., and Bartles J.R. The deaf jerker mouse has a mutation in the gene encoding the espin actin-bundling proteins of hair cell stereocilia and lacks espins. Cell 102 (2000) 377-385